Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role core
2

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000

MAL-PEG-DSPE
Type Polymer
Formula
Role layer
3

lecithin

Type Complex Compound
Formula
Role layer
4

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material
5

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

General physical and chemical properties

Property Value Source
colloidal stability dependent on precursor ratio

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
BALB/c mouse xenografted with human liver hepatocellular HepG2 cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • doxorubicin hydrogen chloride
  1. C9USFZ9d7LjNV
  2. LANVuBCkxc4h7
  3. zrpctSQq
Product

doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

Method 2

Type: Physical formation
Source:
Starting materials
Product

doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial